Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219,200 | 205,800 | 167,900 | 200,700 | 247,400 |
| Receivables | 1,196,000 | 1,157,100 | 1,145,400 | 1,129,000 | 1,164,600 |
| Inventories | 770,900 | 737,100 | 671,700 | 689,600 | 713,500 |
| Other current assets | 256,900 | 277,100 | 243,100 | 214,200 | 232,100 |
| TOTAL | $2,443,000 | $2,377,100 | $2,228,100 | $2,233,500 | $2,357,600 |
| Non-Current Assets | |||||
| PPE Net | 2,517,500 | 2,464,400 | 2,491,300 | 2,412,900 | 2,456,700 |
| Intangibles | 1,874,400 | 1,817,900 | 1,791,300 | 0 | 0 |
| Other Non-Current Assets | 591,800 | 589,200 | 576,500 | 2,281,900 | 2,319,900 |
| TOTAL | $4,983,700 | $4,871,500 | $4,859,100 | $4,694,800 | $4,776,600 |
| Total Assets | $7,426,700 | $7,248,600 | $7,087,200 | $6,928,300 | $7,134,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 359,700 | 315,200 | 298,500 | 444,100 | 353,900 |
| Accounts payable and accrued liabilities | 684,200 | 695,900 | 728,300 | 653,800 | 663,500 |
| TOTAL | $2,325,400 | $2,340,900 | $2,148,700 | $2,290,900 | $2,167,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,995,800 | 3,165,400 | 3,210,800 | 3,072,100 | 3,283,700 |
| aiOther Non-Current Liabilities | 869,200 | 915,200 | 888,600 | 766,700 | 759,900 |
| TOTAL | $4,387,700 | $4,571,500 | $4,588,200 | $4,314,000 | $4,493,900 |
| Total Liabilities | $6,713,100 | $6,912,400 | $6,736,900 | $6,604,900 | $6,661,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,076,034 | 1,076,070 | 1,074,543 | 1,076,527 | 1,085,177 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 6,965,300 | 6,616,000 | 6,518,500 | 6,285,200 | 6,052,500 |
| Other shareholders' equity | -2,148,100 | -2,207,500 | -2,206,000 | -2,152,700 | -2,026,000 |
| TOTAL | $713,600 | $336,200 | $350,300 | $323,400 | $472,600 |
| Total Liabilities And Equity | $7,426,700 | $7,248,600 | $7,087,200 | $6,928,300 | $7,134,200 |